Movers Offered Professional Advice On Choosing The Best 16-03-2023, 04:39

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00

Ortoli Rosenstadt LLP Announces the Third Annual ORY APAC-US Conference on July 8-9, 2025 at Capella Singapore 3-07-2025, 20:00